Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 7
2021 5
2022 2
2023 6
2024 6
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Blood Monocyte Phenotype Is A Marker of Cardiovascular Risk in Type 2 Diabetes.
Julla JB, Girard D, Diedisheim M, Saulnier PJ, Tran Vuong B, Blériot C, Carcarino E, De Keizer J, Orliaguet L, Nemazanyy I, Potier C, Khider K, Tonui DC, Ejlalmanesh T, Ballaire R, Mambu Mambueni H, Germain S, Gaborit B, Vidal-Trécan T, Riveline JP, Garchon HJ, Fenaille F, Lemoine S, Carlier A, Castelli F, Potier L, Masson D, Roussel R, Vandiedonck C, Hadjadj S, Alzaid F, Gautier JF, Venteclef N. Julla JB, et al. Circ Res. 2024 Jan 19;134(2):189-202. doi: 10.1161/CIRCRESAHA.123.322757. Epub 2023 Dec 28. Circ Res. 2024. PMID: 38152893 Free article.
Fully automated epicardial adipose tissue volume quantification with deep learning and relationship with CAC score and micro/macrovascular complications in people living with type 2 diabetes: the multicenter EPIDIAB study.
Gaborit B, Julla JB, Fournel J, Ancel P, Soghomonian A, Deprade C, Lasbleiz A, Houssays M, Ghattas B, Gascon P, Righini M, Matonti F, Venteclef N, Potier L, Gautier JF, Resseguier N, Bartoli A, Mourre F, Darmon P, Jacquier A, Dutour A. Gaborit B, et al. Among authors: julla jb. Cardiovasc Diabetol. 2024 Sep 3;23(1):328. doi: 10.1186/s12933-024-02411-y. Cardiovasc Diabetol. 2024. PMID: 39227844 Free PMC article.
High glycemic variability is associated with a reduced T cell cytokine response to influenza A virus.
Tong MZW, Hulme KD, Law SC, Noye E, Dorey ES, Chew KY, Rowntree LC, van de Sandt CE, Kedzierska K, Goeijenbier M, Ronacher K, Alzaid F, Julla JB, Riveline JP, Lineburg KE, Smith C, Grant EJ, Gras S, Gallo LA, Barrett HL, Short KR. Tong MZW, et al. Among authors: julla jb. iScience. 2024 Oct 11;27(11):111166. doi: 10.1016/j.isci.2024.111166. eCollection 2024 Nov 15. iScience. 2024. PMID: 39524368 Free PMC article.
Management of patients with type 2 diabetes and MASLD: An overview and joint statement.
Chouik Y, Canivet CM, Julla JB, Mouillot T, Parlati L, Rouland A, Smati S, Tramunt B, Anty R, Boursier J, Carette C, Cariou B, Castera L, Garioud A, Guerci B, Gourdy P, Guillaume M, Lassailly G, Pais R, Petit JM, Serfaty L, Vergès B, Caussy C; AFEF and SFD. Chouik Y, et al. Among authors: julla jb. Diabetes Metab. 2025 Oct 15;51(6):101709. doi: 10.1016/j.diabet.2025.101709. Online ahead of print. Diabetes Metab. 2025. PMID: 41106720 Free article.
Effectiveness of Six International Guidelines Using Fibrosis-4 and FibroScan for Risk Stratification of Metabolic Dysfunction-associated Steatotic Liver Disease in Type 2 Diabetes.
Vidal-Trécan T, Julla JB, El Khoury T, Venteclef N, Riveline JP, Paradis V, Valla D, Gautier JF, Castera L. Vidal-Trécan T, et al. Among authors: julla jb. Clin Gastroenterol Hepatol. 2025 Nov;23(12):2176-2186.e2. doi: 10.1016/j.cgh.2025.02.018. Epub 2025 May 8. Clin Gastroenterol Hepatol. 2025. PMID: 40348110
ACBP/DBI neutralization for the experimental treatment of fatty liver disease.
Motiño O, Lambertucci F, Joseph A, Durand S, Anagnostopoulos G, Li S, Carbonnier V, Nogueira-Recalde U, Montégut L, Chen H, Aprahamian F, Nirmalathasan N, Maiuri MC, Pietrocola F, Valla D, Laouénan C, Gautier JF, Castera L; QUID NASH Investigators; Martins I, Kroemer G. Motiño O, et al. Cell Death Differ. 2025 Mar;32(3):434-446. doi: 10.1038/s41418-024-01410-6. Epub 2024 Nov 16. Cell Death Differ. 2025. PMID: 39550516 Free PMC article.
Beyond overweight, visceral adiposity is associated with estimation of cardiovascular risk in patients living with type 1 diabetes: findings from the SFDT1 cohort.
Salle L, Julla JB, Fagherazzi G, Gourdy P, Bezerra Parente E, Hanaire H, Tatulashvili S, Disse E, Franc S, Hadjadj S, Larger E, Sanz C, Vaduva P, Valero R, Bonnefond A, Cosson E, Aguayo GA, Riveline JP; SFDT1 group. Salle L, et al. Among authors: julla jb. Cardiovasc Diabetol. 2025 Jun 14;24(1):256. doi: 10.1186/s12933-025-02789-3. Cardiovasc Diabetol. 2025. PMID: 40517273 Free PMC article.
Early macrophage response to obesity encompasses Interferon Regulatory Factor 5 regulated mitochondrial architecture remodelling.
Orliaguet L, Ejlalmanesh T, Humbert A, Ballaire R, Diedisheim M, Julla JB, Chokr D, Cuenco J, Michieletto J, Charbit J, Lindén D, Boucher J, Potier C, Hamimi A, Lemoine S, Blugeon C, Legoix P, Lameiras S, Baudrin LG, Baulande S, Soprani A, Castelli FA, Fenaille F, Riveline JP, Dalmas E, Rieusset J, Gautier JF, Venteclef N, Alzaid F. Orliaguet L, et al. Among authors: julla jb. Nat Commun. 2022 Aug 30;13(1):5089. doi: 10.1038/s41467-022-32813-z. Nat Commun. 2022. PMID: 36042203 Free PMC article.
31 results